Combating the Global Antibiotic Resistance Crisis
Join the International Journal of Antibiotic Research (IJANR) for priority publication in antimicrobial discovery, resistance mechanisms, stewardship programs, and novel therapeutic strategies. Our global community connects microbiologists, infectious disease specialists, and pharmaceutical researchers advancing solutions to the mounting antimicrobial resistance crisis threatening public health worldwide. From molecular mechanisms to clinical outcomes, IJANR publishes research that addresses one of the most urgent challenges facing modern medicine and global health security.
Critical Research Priority
- Novel antibiotic discovery and development
- Resistance mechanism elucidation
- Antimicrobial stewardship interventions
- Alternative antimicrobial strategies
- One Health approaches to resistance
Excellence in Antimicrobial Research Publishing
Expert Microbiology Review
Manuscripts reviewed by microbiologists, infectious disease physicians, and pharmaceutical scientists who understand resistance mechanisms, drug development pathways, and clinical relevance requirements for antimicrobial research advancing the fight against resistant pathogens worldwide.
Rapid 21-Day Decisions
Streamlined review delivers decisions within 21 days, essential for time-sensitive antimicrobial research where emerging resistance patterns and novel antibiotic discoveries require rapid dissemination to researchers and clinicians managing resistant infections globally.
Global Open Access
Published research reaches microbiologists, clinicians, and public health officials worldwide without barriers, ensuring antimicrobial findings translate into improved stewardship, therapeutic strategies, and policy decisions across healthcare systems and research institutions.
Translational Focus
Priority given to research bridging basic microbiology with clinical infectious disease practice, from laboratory discovery of new antimicrobials to clinical trials validating stewardship interventions and novel therapeutic approaches for resistant infections.
One Health Perspective
Antimicrobial resistance spans human, animal, and environmental domains. IJANR welcomes research adopting One Health approaches to understand resistance transmission, agricultural antibiotic use, and the ecological dimensions of antimicrobial resistance.
Industry Collaboration
Connect research with pharmaceutical partners developing new antimicrobials. IJANR publishes preclinical and clinical trial data advancing antibiotic development pipelines addressing the critical need for new therapeutic options against resistant pathogens.
Investment Options
All tiers include rigorous peer review, DOI assignment, and comprehensive indexing for maximum visibility
- 1 Article APC Waiver
- Unlimited submissions
- Priority review handling
- Language editing services
- 2 Article APC Waivers
- Expedited review process
- Editorial board eligibility
- Membership certificate
- Coverage for 25 articles
- Centralized billing
- Multiple researcher support
- Dedicated account manager
Antimicrobial Research Focus Areas
Antibiotic Discovery
New antibiotics are essential to combat resistance. IJANR publishes research on natural product discovery, synthetic antibiotic development, novel targets, and innovative screening approaches that expand the antimicrobial pipeline with compounds active against priority resistant pathogens designated by the World Health Organization.
Resistance Mechanisms
Understanding resistance enables therapeutic solutions. IJANR welcomes research on efflux pumps, beta-lactamases, target modification, horizontal gene transfer, and the molecular and genetic basis of antimicrobial resistance that informs development of resistance-breaking strategies and combination therapies.
Antimicrobial Stewardship
Optimizing antibiotic use preserves effectiveness. IJANR publishes research on stewardship program implementation, prescribing interventions, diagnostic-guided therapy, and healthcare system approaches to reducing inappropriate antibiotic use while maintaining optimal patient outcomes.
Clinical Infectious Disease
Translating research to patient care remains paramount. IJANR welcomes clinical studies on antibiotic therapy optimization, pharmacokinetic-pharmacodynamic relationships, treatment of resistant infections, and outcomes research guiding therapeutic decision-making for challenging infectious diseases.
Alternative Therapeutics
Beyond conventional antibiotics lie novel approaches. IJANR publishes research on bacteriophage therapy, antimicrobial peptides, immunomodulatory strategies, CRISPR-based antimicrobials, and innovative therapeutic modalities offering alternatives to traditional antibiotic approaches.
Epidemiology and Surveillance
Tracking resistance patterns guides public health response. IJANR welcomes research on resistance surveillance, outbreak investigation, molecular epidemiology, and global resistance trends informing policy decisions and public health interventions across healthcare and community settings.
Agricultural and Environmental
Resistance connects human, animal, and environmental health. IJANR publishes research on veterinary antibiotic use, agricultural resistance, environmental reservoirs, and One Health approaches to understanding and mitigating antimicrobial resistance across interconnected ecosystems.
Diagnostic Innovation
Rapid diagnostics enable targeted therapy. IJANR welcomes research on rapid susceptibility testing, molecular resistance detection, point-of-care diagnostics, and technological advances enabling faster identification of resistant pathogens and appropriate antibiotic selection.
Drug Development Pipeline
From bench to bedside requires systematic research. IJANR publishes preclinical and clinical studies advancing antibiotic candidates through development phases, addressing the critical need for new antimicrobials against resistant Gram-negative bacilli, carbapenemases, and other priority pathogens.
Editorial Opportunities
Join our editorial board to shape antimicrobial resistance research publishing. Handle manuscripts in your expertise from basic microbiology to clinical infectious disease. Propose special issues on emerging resistance threats, novel therapeutic strategies, and global stewardship initiatives.
IJANR maintains strict editorial independence. All submissions undergo rigorous double-blind peer review regardless of membership tier. Our reviewers evaluate manuscripts for scientific rigor, methodological quality, and potential to advance solutions to antimicrobial resistance. This ensures the IJANR seal represents excellence in antibiotic research serving microbiologists, clinicians, pharmaceutical developers, and public health institutions combating the resistance crisis worldwide.
Ready to Publish Your Antibiotic Research?
Submit for expert peer review by microbiologists and infectious disease specialists. Contact [email protected] for membership inquiries. Whether discovering new antibiotics, elucidating resistance mechanisms, or evaluating stewardship interventions, IJANR provides expert reviewers and global visibility for impactful antimicrobial resistance research that addresses urgent clinical and public health needs.